FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Notice of Field Correction: Haemonetics MCS+ 9000,
Cell Saver 5, Cell Saver 5+

horizontal rule

DATE NOTIFICATION INITIATED:

    December 15, 2005

PRODUCT / MODEL NUMBER

    Haemonetics LN9000 Collection System (Model Number: LN9000-110-E)

    Serial Numbers: 05D056; 05F064-1; 05F065; 05G101; 05G103; 05H094

    Haemonetics Cell Saver 5 Autologous Blood Recovery System (Model Number: LN02005-110-E)

    Serial Numbers: 94H180CD-1; 95A048CS; 95J177CS

    Haemonetics Cell Saver 5+ Autologous Blood Recovery System (Model Number LN02005-110EP)

    Serial Numbers: 05F022-1; 05F023-1; 05H103;05C083-05C084; 05C087-05C089;05D006-05D011;05D037--05D040; 05D043-05D047;05D060-05D068; 05D080--05D081; 05D085-05D089; 05E026-05E035;05E054-1; 05E055-1; 05E056;05E061-05E070; 05E091-05E095; 05F021; 05F066-05F072; 05F098-05F107;05F142-05F144; 05F147; 05F149; 05F150; 05F157-05F159;05G008-1; 05G009-05G012; 05G035-05G037; 05G038-1; 05G055-1; 05G057-05G059; 05G080-05G084;05H018; 05H022; 05H024- 05H027; 05H073-05H077; 05H100-05H101; 05H104; 05H163; 05J185-05J189; 05K011-05K013; 05K015-05K017; 05K092-05K096; 05K168-05K173 ; 05K175; 05K201

MANUFACTURER:

    Haemonetics Corporation
    Braintree, Massachusetts

REASON:

    Haemonetics has become aware that the Liquid Crystal Display (LCD) on the above listed devices may emit radiofrequency waves that exceed the level permitted by International Standards. Haemonetics is executing a field correction to upgrade devices with a new, compliant LCD.

horizontal rule

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

 

Updated March 9, 2006
 
horizontal rule

CBER Home Page | CBER A-Z Index | CBER Search | Contact CBER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA / Center for Biologics Evaluation and Research